These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21954237)

  • 21. Informing the efficient use of health care and health care research resources - the case of screening for abdominal aortic aneurysm in Sweden.
    Henriksson M; Lundgren F; Carlsson P
    Health Econ; 2006 Dec; 15(12):1311-22. PubMed ID: 16786498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening individuals with intracranial aneurysms for abdominal aortic aneurysms is cost-effective based on estimated coprevalence.
    Ball BZ; Jiang B; Mehndiratta P; Stukenborg GJ; Upchurch GR; Meschia JF; Worrall BB; Southerland AM
    J Vasc Surg; 2016 Sep; 64(3):811-818.e3. PubMed ID: 27565600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presentation of economic evaluation results.
    Chaikledkaew U
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S72-80. PubMed ID: 24964702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Screening for abdominal aortic aneurysm; effectivity and cost-effectiveness].
    van Gils PF; de Wit GA; Schuit AJ; van den Berg M
    Ned Tijdschr Geneeskd; 2009; 153():B383. PubMed ID: 19857301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of endovascular versus open surgical repair of acute abdominal aortic aneurysms based on worldwide experience.
    Hayes PD; Sadat U; Walsh SR; Noorani A; Tang TY; Bowden DJ; Gillard JH; Boyle JR
    J Endovasc Ther; 2010 Apr; 17(2):174-82. PubMed ID: 20426633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guidelines for multi-model comparisons of the impact of infectious disease interventions.
    den Boon S; Jit M; Brisson M; Medley G; Beutels P; White R; Flasche S; Hollingsworth TD; Garske T; Pitzer VE; Hoogendoorn M; Geffen O; Clark A; Kim J; Hutubessy R
    BMC Med; 2019 Aug; 17(1):163. PubMed ID: 31422772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abdominal aortic aneurysms.
    Lindholt JS
    Dan Med Bull; 2010 Dec; 57(12):B4219. PubMed ID: 21122465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The generalisability of pharmacoeconomic studies: issues and challenges ahead.
    Mason JM; Mason AR
    Pharmacoeconomics; 2006; 24(10):937-45. PubMed ID: 17002476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leveraging the electronic medical record to implement an abdominal aortic aneurysm screening program.
    Hye RJ; Smith AE; Wong GH; Vansomphone SS; Scott RD; Kanter MH
    J Vasc Surg; 2014 Jun; 59(6):1535-42. PubMed ID: 24507825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health economic decision-making: a comparison between UK and Spain.
    Corbacho B; Pinto-Prades JL
    Br Med Bull; 2012 Sep; 103(1):5-20. PubMed ID: 22833571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying priority technical and context-specific issues in improving the conduct, reporting and use of health economic evaluation in low- and middle-income countries.
    Luz A; Santatiwongchai B; Pattanaphesaj J; Teerawattananon Y
    Health Res Policy Syst; 2018 Feb; 16(1):4. PubMed ID: 29402314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model.
    Burch J; Hinde S; Palmer S; Beyer F; Minton J; Marson A; Wieshmann U; Woolacott N; Soares M
    Health Technol Assess; 2012; 16(34):1-157, iii-iv. PubMed ID: 22985954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation.
    Fleeman N; McLeod C; Bagust A; Beale S; Boland A; Dundar Y; Jorgensen A; Payne K; Pirmohamed M; Pushpakom S; Walley T; de Warren-Penny P; Dickson R
    Health Technol Assess; 2010 Jan; 14(3):1-157, iii. PubMed ID: 20031087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review of guidelines on abdominal aortic aneurysm screening.
    Ferket BS; Grootenboer N; Colkesen EB; Visser JJ; van Sambeek MR; Spronk S; Steyerberg EW; Hunink MG
    J Vasc Surg; 2012 May; 55(5):1296-1304. PubMed ID: 21324630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Replicating Health Economic Models: Firm Foundations or a House of Cards?
    Bermejo I; Tappenden P; Youn JH
    Pharmacoeconomics; 2017 Nov; 35(11):1113-1121. PubMed ID: 28748450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recalibrating the notion of modelling for policymaking during pandemics.
    Teerawattananon Y; Kc S; Chi YL; Dabak S; Kazibwe J; Clapham H; Lopez Hernandez C; Leung GM; Sharifi H; Habtemariam M; Blecher M; Nishtar S; Sarkar S; Wilson D; Chalkidou K; Gorgens M; Hutubessy R; Wibulpolprasert S
    Epidemics; 2022 Mar; 38():100552. PubMed ID: 35259693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using system dynamics modelling to assess the economic efficiency of innovations in the public sector - a systematic review.
    Jadeja N; Zhu NJ; Lebcir RM; Sassi F; Holmes A; Ahmad R
    PLoS One; 2022; 17(2):e0263299. PubMed ID: 35143541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reporting guidelines for modelling studies.
    Bennett C; Manuel DG
    BMC Med Res Methodol; 2012 Nov; 12():168. PubMed ID: 23134698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bridging the gap between evidence and policy for infectious diseases: How models can aid public health decision-making.
    Knight GM; Dharan NJ; Fox GJ; Stennis N; Zwerling A; Khurana R; Dowdy DW
    Int J Infect Dis; 2016 Jan; 42():17-23. PubMed ID: 26546234
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.